Drug Interactions between abiraterone and Adderall
This report displays the potential drug interactions for the following 2 drugs:
- abiraterone
- Adderall (amphetamine/dextroamphetamine)
Interactions between your drugs
amphetamine abiraterone
Applies to: Adderall (amphetamine / dextroamphetamine) and abiraterone
Abiraterone may increase the blood levels and effects of amphetamine. You may need a dose adjustment or more frequent monitoring by your doctor to safely use both medications. Contact your doctor if your condition changes or you experience increased side effects. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
dextroamphetamine abiraterone
Applies to: Adderall (amphetamine / dextroamphetamine) and abiraterone
Consumer information for this interaction is not currently available.
GENERALLY AVOID: Coadministration with abiraterone acetate may increase the plasma concentrations of CYP450 2D6 substrates via inhibition of this isoenzyme. This may increase the risk of adverse reactions for drugs that are metabolized by CYP450 2D6 (e.g., metoprolol, propranolol, desipramine, venlafaxine, haloperidol, risperidone, propafenone, flecainide). When dextromethorphan, a CYP450 2D6 substrate, was given with abiraterone acetate 1,000 mg daily and prednisone 5 mg twice daily, dextromethorphan peak plasma concentration (Cmax) and systemic exposure (AUC) increased by 2.8- and 2.9-fold, respectively, compared to administration alone. Conversely, drugs that utilize CYP450 2D6 to form their active metabolites may have reduced efficacy (e.g., codeine, oxycodone, tramadol).
MANAGEMENT: Concurrent therapy of abiraterone acetate with CYP450 2D6 substrates, particularly those for which minimal changes in concentration could lead to serious toxicities, is not generally recommended. If an alternative treatment cannot be used, a dose adjustment and an increase in monitoring of the CYP450 2D6 substrate should be considered. Consult the prescribing information for more specific recommendations.
Drug and food interactions
amphetamine food
Applies to: Adderall (amphetamine / dextroamphetamine)
Using amphetamine together with alcohol can increase the risk of cardiovascular side effects such as increased heart rate, chest pain, or blood pressure changes. You should avoid or limit the use of alcohol while being treated with amphetamine. Let your doctor know if you experience severe or frequent headaches, chest pain, and/or a fast or pounding heartbeat. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
dextroamphetamine food
Applies to: Adderall (amphetamine / dextroamphetamine)
Using dextroamphetamine together with alcohol can increase the risk of cardiovascular side effects such as increased heart rate, chest pain, or blood pressure changes. You should avoid or limit the use of alcohol while being treated with dextroamphetamine. Let your doctor know if you experience severe or frequent headaches, chest pain, and/or a fast or pounding heartbeat. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
abiraterone food
Applies to: abiraterone
This interaction does not apply to abiraterone acetate (Yonsa) 125 mg tablets, which can be taken with or without food.
Taking abiraterone with food increases the amount of medicine that gets absorbed by the body for certain formulations. This may increase the risk of side effects such as high blood pressure, water retention, and a condition called hypokalemia (low blood potassium), which in severe cases can lead to muscle weakness, paralysis, breathing and swallowing difficulties (due to muscle paralysis), and irregular heart rhythm. You should take abiraterone once a day on an empty stomach. No food should be eaten for at least two hours before and one hour after taking abiraterone. Let your doctor know if you experience nausea, vomiting, constipation, abdominal cramping, confusion, dizziness, lightheadedness, fainting, muscle weakness, muscle cramps, numbness or tingling, rapid heartbeat, chest pain, and/or swelling in the legs or feet, as these may be symptoms of hypokalemia or excessive effects of abiraterone. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
See also
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.